Showing results (11-20 of 108) with videos related to
Sort By:
Pageof 11
Current Alzheimer Research|June 25, 2005
New insights into serotonin 5-HT4 receptors : a novel therapeutic target for Alzheimer's disease?Marjorie Maillet, Sylvain J Robert, Frank Lezoualc'hCurrent Drug Discovery Technologies|December 17, 2008
Bivalent ligands as specific pharmacological tools for G protein-coupled receptor dimersIsabelle Berque-Bestel, Frank Lezoualc'h, Ralf JockersJournal of Cardiovascular Development and Disease|February 7, 2018
Epac Function and cAMP Scaffolds in the Heart and LungMarion Laudette, Haoxiao Zuo, Frank Lezoualc'h, et al.Circulation Research|March 5, 2016
Cyclic AMP Sensor EPAC Proteins and Their Role in Cardiovascular Function and DiseaseFrank Lezoualc'h, Loubina Fazal, Marion Laudette, et al.Vascular Biology (Bristol, England)|March 13, 2020
Targeting epigenetic mechanisms as an emerging therapeutic strategy in pulmonary hypertension diseaseMalik Bisserier, Radoslav Janostiak, Frank Lezoualc'h, et al.Biochemical Society Transactions|January 21, 2012
Role of Epac in brain and heartAnne-Coline Laurent, Magali Breckler, Magali Berthouze, et al.Current Heart Failure Reports|May 20, 2011
New perspectives in cAMP-signaling modulationMagali Berthouze, Anne-Coline Laurent, Magali Breckler, et al.Medecine Sciences : M/S|October 21, 2015
[Molecular determinants of pathological cardiac remodeling: the examples of Epac and Carabin]Yannis Sainte-Marie, Malik Bisserier, Florence Tortosa, et al.Current Topics in Medicinal Chemistry|February 20, 2010
Review of 5-HT4R ligands: state of art and clinical applicationsRonan Bureau, Michel Boulouard, François Dauphin, et al.Journal of Molecular and Cellular Cardiology|March 15, 2008
Small GTP-binding proteins and their regulators in cardiac hypertrophyFrank Lezoualc'h, Mélanie Métrich, Isabelle Hmitou, et al.Pageof 11